Entasis Therapeutics   Report issue

For profit Phase 1 Phase 3
Founded: Waltham MA United States (2015)

Organization Overview

First Clinical Trial
2015
NCT02298920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Entasis Therapeutics